Zero Candida market set to reach over US$2 billion by 2030
Propel Healthtech West Yorkshire has opened applications for its final 2026 healthtech cohort, offering innovators support to scale solutions for the NHS and wider healthcare…
Propel Healthtech West Yorkshire has opened applications for its final 2026 healthtech cohort, offering innovators support to scale solutions for the NHS and wider healthcare…
Image: SONATA SONATA, a physician-led preventive healthcare membership, has launched in New York, San Francisco, and Los Angeles with $7 million in backing from Lux…
THE FORMER Health Minister, Lord Hutton, has called for an NHS Rapid Upgrade Programme to unlock up to £16 billion of private investment, urging the Government to modernise NHS hospitals through existing PFI contracts…
Image: Daye A new paper from Daye‘s research team, together with researchers at UCL, Queen Mary University of London, and the London School of Hygiene…
RUXOLITINIB cream improved moderate atopic dermatitis and rapidly reduced itch after other topical treatments had failed. Ruxolitinib Cream Improves Atopic Dermatitis Outcomes Adults with moderate…
Nearly six in ten young women get health and wellness advice from influencers, new research shows. Women aged 18 to 29 were more likely than…
Veradermics, a dermatologist-founded biopharmaceutical company, has reported positive topline results from the female treatment arms of its Phase 2 open-label Study ‘207’ evaluating VDPHL01, a…
BMS is set to strengthen its AI-driven drug discovery capabilities through a new collaboration with NVIDIA, deploying a DGX SuperPOD powered by the company’s next-generation Vera Rubin…
Juno Bio has secured US$3.8m to expand its diagnostics platform for vaginal health and reproductive care. The funding round was led by Ada Ventures, with…
The FDA has approved Celcuity‘s REVTORPYK (gedatolisib) for HR+/HER2-, locally advanced or metastatic breast cancer without a PIK3CA mutation, following progression on or after at…